Cargando…
Clinical implementation of integrated molecular‐morphologic risk prediction for meningioma
Risk prediction for meningioma tumors was until recently almost exclusively based on morphological features of the tumor. To improve risk prediction, multiple models have been established that incorporate morphological and molecular features for an integrated risk prediction score. One such model is...
Autores principales: | Hielscher, Thomas, Sill, Martin, Sievers, Philipp, Stichel, Damian, Brandner, Sebastian, Jones, David T. W., von Deimling, Andreas, Sahm, Felix, Maas, Sybren L. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154374/ https://www.ncbi.nlm.nih.gov/pubmed/36377252 http://dx.doi.org/10.1111/bpa.13132 |
Ejemplares similares
-
Integrated Molecular-Morphologic Meningioma Classification: A
Multicenter Retrospective Analysis, Retrospectively and Prospectively
Validated
por: Maas, Sybren L. N., et al.
Publicado: (2021) -
Analysis of recurrence probability following radiotherapy in patients with CNS WHO grade 2 meningioma using integrated molecular-morphologic classification
por: Deng, Maximilian Y, et al.
Publicado: (2023) -
PATH-26. RNA SEQUENCING OF FORMALIN-FIXED PARAFFIN-EMBEDDED SPECIMENS IN DIAGNOSTIC ROUTINE IDENTIFIES CLINICALLY RELEVANT GENE FUSIONS
por: Stichel, Damian, et al.
Publicado: (2020) -
CDKN2A/B homozygous deletion is associated with early recurrence in meningiomas
por: Sievers, Philipp, et al.
Publicado: (2020) -
LGG-33. ISOMORPHIC DIFFUSE GLIOMA HAS RECURRENT GENE FUSIONS OF MYBL1 OR MYB AND CAN BE DISTINGUISHED FROM OTHER MYB/MYBL1 ALTERED GLIOMAS BASED ON A DISTINCT MORPHOLOGY AND DNA METHYLATION PROFILE
por: Wefers, Annika K, et al.
Publicado: (2020)